ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

MXCT Maxcyte Inc

370.00
5.00 (1.37%)
10 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Maxcyte Inc LSE:MXCT London Ordinary Share COM STK USD0.01 (DI)
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  5.00 1.37% 370.00 370.00 380.00 375.00 365.00 365.00 30,953 16:35:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Biological Pds,ex Diagnstics 41.29M -37.92M -0.3664 -12.91 489.58M
Maxcyte Inc is listed in the Biological Pds,ex Diagnstics sector of the London Stock Exchange with ticker MXCT. The last closing price for Maxcyte was 365p. Over the last year, Maxcyte shares have traded in a share price range of 172.50p to 420.00p.

Maxcyte currently has 103,504,571 shares in issue. The market capitalisation of Maxcyte is £489.58 million. Maxcyte has a price to earnings ratio (PE ratio) of -12.91.

Maxcyte Share Discussion Threads

Showing 951 to 974 of 1500 messages
Chat Pages: Latest  48  47  46  45  44  43  42  41  40  39  38  37  Older
DateSubjectAuthorDiscuss
14/9/2021
09:36
Just quoting the figures from the accounts mysteronz. Perhaps you have better figures.
trident5
14/9/2021
09:25
Trident hasn’t got a clue basically.
mysteronz
14/9/2021
09:21
I think that was stock option revaluation due to the increase in the share price
wjccghcc
14/9/2021
08:58
In the accounts: revenue grew by $2.3m and compensation by $5.8m!!
trident5
14/9/2021
08:37
Trident5 - where are compensation increases disclosed?
adamb1978
14/9/2021
08:04
Placing cash funding big compensation increases.
trident5
14/9/2021
07:44
Transcript of last night's call
homebrewruss
13/9/2021
21:49
Just listening to the conference call. Not sure that I've heard much to move things in either direction at the moment, or much different, though I guess its a long-term story stock to that shouldnt be a surprise
adamb1978
09/9/2021
18:14
All grist to the mill!.
I wonder what this particular approval will be worth to Maxcyte.

assagai
09/9/2021
16:49
Fast track approval for Maxcyte partner drug.
acuere
09/9/2021
10:05
Strange number of zero trades going thru. Including one at 20:20 last night shown at a price of 1234.9845p
Any thoughts what these mean?

acuere
09/9/2021
08:48
Sorry wrong thread
big7ime
07/9/2021
19:38
Another blog/note on MXCT
'MaxCyte's snowball effect: Riding on the shoulders of top CRISPR companies'

homebrewruss
06/9/2021
18:30
Interesting blog posting on Maxcyte

MaxCyte: Enabling Next-Generation Cell Based Therapies, Attractive Risk-Return Profile.

pob69
06/9/2021
14:03
It's Labor Day in the US, so we're "all on our own" today
thetrotsky
03/9/2021
22:59
190k after hours sell. So 2million squids worth moved into new hands. Nice base.
assagai
02/9/2021
16:20
Philip Rodrigs, manager of Raynar Flagship fund, explains why he invests in life sciences company MaxCyte (MXCT).
pob69
02/9/2021
13:41
Thanks Pob69, a week earlier than anticipated.

Well its on my NAS monitor but not UK?

assagai
02/9/2021
13:17
Hasn't been RNSed but Q2 out on 13/9
pob69
02/9/2021
08:35
Filtering is not enough for me, multibagger. Although I hope you stay on 😊

I've removed MXCT from my favourites list. Pity, but look at the other boards that have been destroyed by trolls and folks feeding them. BOO is a good current example.
I suspect that a lot of (mostly) lurkers disappear too.

Such a shame.

apad

apad
02/9/2021
08:08
T5, Stop being a numpty yourself. The Investopedia definition is misleading. A company's share price at any given time is generally accepted to represent the market's notional estimate of its discounted future earnings (the present value of future cash flows; generally, but not always, less than the actual cash flows) plus the market value (or cash value if you prefer) of its net assets as at that date. I would accept that, in principle, my share of the company's discounted future earnings has (potentially) been reduced by the new share issue but the company's net assets have been enhanced (by the additional cash) and, because the new shares were issued at a premium, the new investors have effectively (more than) compensated me for the expected reduction in my share of the discounted future earnings. As I've already said, a new share issue at a (significant) premium is extremely rare in my experience. Furthermore, I say "potentially" because although the new investment may not change the company's expected future earnings it may have accelerated them, with a consequential knock on effect that the company's discounted future earnings may well have increased. It's all in the maths.
thetrotsky
02/9/2021
07:09
Good morning Nimbo1 and Assagai,

I have added another to the "filtered" crew now....best to leave them to their style of investing.

multibagger
01/9/2021
23:03
So proud mum and dad go to Johnny's passing out parade. The band strikes up, the cadets go by the left, quick march. Mum turns to Dad in horror and exclaims. "I don't believe it , just look at that, every single one of them is marching out of step......except our little Johnny of course.
assagai
01/9/2021
22:40
For the numpties:
trident5
Chat Pages: Latest  48  47  46  45  44  43  42  41  40  39  38  37  Older

Your Recent History

Delayed Upgrade Clock